MarketCap
Facebook
X
Telegram
BeiGene, Ltd. Balance Sheet 2025-2011 | BGNE
Brief overview of BeiGene, Ltd.'s assets and capital
This overview follows the five latest available annual observations between 2021 and 2025.
Assets shifted from $8.5 billion to $8.2 billion, leaving five-period growth close to stagnation.
Liabilities expanded faster than the asset base, +59.3% versus -4.1%. Debt-service capacity deserves attention.
Equity funds 53.3% of assets versus 71.8% initially. This creates a conservative balance sheet structure.
Cash exceeds interest-bearing debt, producing net debt of -$3.6 billion. The balance sheet therefore carries a net cash position.
The cash reserve occupies 55.5% of the balance sheet, previously 51.3%. It is one marker of short-term resilience.
The balance sheet includes a negative accumulated result of -$8.3 billion. It should be assessed alongside historical profits and capital distributions.
What the balance sheet shows
BeiGene, Ltd. retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet BeiGene, Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-3.56 B | -2.44 B | -2.95 B | -3.64 B | -4.15 B | -1.18 B | -12.6 M | -515 M | -74.9 M | 210 M | 2.92 M | -60 K | 23.4 M | - | - |
Long Term Debt |
962 M | 166 M | 198 M | 209 M | 202 M | 184 M | 241 M | 190 M | 155 M | 17.3 M | 6.19 M | 13.5 M | 15.2 M | - | - |
Long Term Debt Current |
20.7 M | 17.6 M | 22 M | 24 M | 21.9 M | 13.9 M | 10.8 M | 8.73 M | 9.22 M | - | - | - | - | - | - |
Total Non Current Liabilities |
2 B | 374 M | 458 M | 527 M | 803 M | 656 M | 324 M | 250 M | 212 M | 17.8 M | 7.27 M | 14.5 M | 18.8 M | - | - |
Total Current Liabilities |
1.83 B | 2.21 B | 1.81 B | 1.47 B | 1.6 B | 1.08 B | 310 M | 246 M | 150 M | 35.1 M | - | - | - | - | - |
Total Liabilities |
3.83 B | 2.59 B | 2.27 B | 2 B | 2.4 B | 1.73 B | 634 M | 496 M | 362 M | 52.9 M | 42.4 M | 27.9 M | 50.5 M | - | - |
Deferred Revenue |
- | - | - | 214 M | 187 M | - | - | 18.1 M | 12.2 M | - | 1.07 M | 8.91 M | 7.86 M | - | - |
Retained Earnings |
-8.32 B | -8.61 B | -7.96 B | -7.08 B | -5.08 B | -3.55 B | -1.96 B | -1.01 B | -331 M | -237 M | -118 M | -61.1 M | -42.8 M | - | - |
Total Assets |
8.19 B | 5.92 B | 5.81 B | 6.38 B | 8.54 B | 5.6 B | 1.61 B | 2.25 B | 1.05 B | 406 M | 117 M | 53.6 M | 11.8 M | - | - |
Cash and Cash Equivalents |
4.55 B | 2.63 B | 3.17 B | 3.87 B | 4.38 B | 1.38 B | 618 M | 713 M | 240 M | 87.5 M | 17.9 M | 13.9 M | - | - | - |
Book Value |
4.36 B | 3.33 B | 3.54 B | 4.38 B | 6.13 B | 3.87 B | 978 M | 1.75 B | 684 M | 353 M | 74.3 M | 25.8 M | -38.7 M | - | - |
Total Shareholders Equity |
4.36 B | 3.33 B | 3.54 B | 4.38 B | 6.13 B | 3.8 B | 962 M | 1.74 B | 670 M | 353 M | -102 M | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet BeiGene, Ltd.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
963 M | 51.4 M | 146 M | 160 M | 44.3 M | 188 M | 185 M | 199 M | 198 M | 202 M | 207 M | 206 M | 209 M | 208 M | 185 M | 202 M | 202 M | 201 M | 195 M | 193 M | 184 M | 184 M | 184 M | 184 M | 83.3 M | 83.3 M | 83.3 M | 83.3 M | 40.8 M | 40.8 M | 40.8 M | 40.8 M | 9.22 M | 9.22 M | 9.22 M | 9.22 M | 17.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
1.98 B | 1.13 B | 318 M | 358 M | 374 M | 369 M | 407 M | 426 M | 458 M | 478 M | 525 M | 545 M | 527 M | 660 M | 677 M | 760 M | 803 M | 625 M | 675 M | 705 M | 656 M | 656 M | 656 M | 656 M | 324 M | 324 M | 324 M | 324 M | 250 M | 250 M | 250 M | 250 M | 212 M | 212 M | 212 M | 212 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 7.27 M | 7.27 M | 7.27 M | 7.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.79 B | 3.5 B | 2.53 B | 2.34 B | 2.59 B | 2.39 B | 2.35 B | 2.31 B | 2.27 B | 1.76 B | 1.93 B | 1.8 B | 2 B | 2.07 B | 2.08 B | 2.14 B | 2.4 B | 1.93 B | 1.92 B | 1.82 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 634 M | 634 M | 634 M | 634 M | 496 M | 496 M | 496 M | 496 M | 362 M | 362 M | 362 M | 362 M | 52.9 M | 52.9 M | 52.9 M | 52.9 M | 42.4 M | 42.4 M | 42.4 M | 42.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | 159 M | 185 M | 214 M | 145 M | 163 M | 164 M | 187 M | 72.6 M | 63.6 M | 71.7 M | - | - | - | - | - | - | - | 17.5 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 12.2 M | 9.13 M | 12.2 M | 12.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-8.09 B | -8.39 B | -8.51 B | -8.61 B | -8.61 B | -8.45 B | -8.33 B | -8.21 B | -7.96 B | -7.59 B | -7.81 B | -7.43 B | -7.08 B | -6.64 B | -5.97 B | -5.4 B | -5.08 B | -4.38 B | -3.97 B | -3.49 B | -3.55 B | -3.55 B | -3.55 B | -3.55 B | -1.96 B | -1.96 B | -1.96 B | -1.96 B | -1.01 B | -1.01 B | -1.01 B | -1.01 B | -331 M | -331 M | -331 M | -331 M | -237 M | -237 M | -237 M | -237 M | -118 M | -118 M | -118 M | -118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
8.55 B | 7.63 B | 6.3 B | 5.84 B | 5.92 B | 5.83 B | 5.71 B | 5.67 B | 5.81 B | 5.52 B | 5.73 B | 5.96 B | 6.38 B | 6.73 B | 7.38 B | 8.02 B | 8.54 B | 5.29 B | 5.52 B | 5.82 B | 5.6 B | 5.6 B | 5.6 B | 5.6 B | 1.61 B | 1.61 B | 1.61 B | 1.61 B | 2.25 B | 2.25 B | 2.25 B | 2.25 B | 1.05 B | 1.05 B | 1.05 B | 1.05 B | 406 M | 406 M | 406 M | 406 M | 117 M | 117 M | 117 M | 117 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
4.79 B | 4.04 B | 2.76 B | 2.52 B | 2.63 B | 2.7 B | 2.59 B | 2.79 B | 3.17 B | 3.07 B | 3.41 B | 3.54 B | 3.87 B | 4.2 B | 4.53 B | 4.35 B | 4.38 B | 1.38 B | 1.78 B | 1.9 B | 1.39 B | 1.38 B | 1.38 B | 1.38 B | 618 M | 618 M | 618 M | 618 M | 713 M | 713 M | 713 M | 713 M | 240 M | 240 M | 240 M | 240 M | 87.5 M | 87.5 M | 87.5 M | 87.5 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 13.9 M | - | - | - | 3.93 M | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
4.76 B | 4.13 B | 3.77 B | 3.5 B | 3.33 B | 3.44 B | 3.37 B | 3.36 B | 3.54 B | 3.76 B | 3.8 B | 4.16 B | 4.38 B | 4.66 B | 5.3 B | 5.89 B | 6.13 B | 3.36 B | 3.61 B | 4 B | 3.87 B | 3.87 B | 3.87 B | 3.87 B | 978 M | 978 M | 978 M | 978 M | 1.75 B | 1.75 B | 1.75 B | 1.75 B | 684 M | 684 M | 684 M | 684 M | 353 M | 353 M | 353 M | 353 M | 74.3 M | 74.3 M | 74.3 M | 74.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
4.76 B | 4.13 B | 3.77 B | 3.5 B | 3.33 B | 3.44 B | 3.37 B | 3.36 B | 3.54 B | 3.76 B | 3.8 B | 4.16 B | 4.38 B | 4.66 B | 5.2 B | 5.77 B | 6.13 B | 3.25 B | 3.53 B | 3.93 B | 3.87 B | 3.87 B | 3.87 B | 3.87 B | 962 M | 962 M | 962 M | 962 M | 1.74 B | 1.74 B | 1.74 B | 1.74 B | 670 M | 670 M | 670 M | 670 M | 353 M | 353 M | 353 M | 353 M | -102 M | -102 M | -102 M | -102 M | -53 M | - | - | - | -37 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of BeiGene, Ltd., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Canada
China
USA
France
Singapore
Britain
Germany
Israel
Russia
Belgium
Niderland
Irlanda
